Precision BioSciences (DTIL) is scheduled to report Q3 earnings on November 2, 2026. Analysts estimate EPS of $-0.88 and quarterly revenue of $833.33K.
In the most recent quarter (Q2), Precision BioSciences reported EPS of $-1.26, missing estimates of $-0.68 by 0.85%. Revenue came in at $0, missing the estimate of $1.78M by 1%.
Precision BioSciences has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Precision BioSciences has averaged an EPS surprise of 1.11% and a revenue surprise of 1.39%.
Earnings Date
Nov 2
EPS Estimate
$-0.880
Quarterly Revenue Estimate
$833.33K
Annual Revenue
$45.05M
as of Jun 30
Analyze the earnings history of Precision BioSciences using advanced sorting and filters.
The chart below shows Precision BioSciences's reported EPS compared to analyst estimates over recent quarters.
The chart below shows Precision BioSciences's reported revenue compared to analyst estimates over recent quarters.
Precision BioSciences (DTIL) is scheduled to report earnings on November 2, 2026. The last reported earnings were for reported on August 6, 2026 for Q2.
The Actual EPS was $-1.26, which missed the estimate of $-0.68.
The Actual Revenue was $0, which missed the estimate of $1.78M.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.26 | $-0.68 | -85.3 % |
| Q1 | May 5, 2026 | $-0.75 | $-0.70 | -7.14 % |
| Q4 | Mar 12, 2026 | $1.05 | $-0.47 | 323.4 % |
| Q3 | Nov 3, 2025 | $-1.84 | $-1.45 | -26.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $1.78M | -100.0 % |
| Q1 | May 5, 2026 | $10.84M | $4.78M | 126.7 % |
| Q4 | Mar 12, 2026 | $34.20M | $10.37M | 230.0 % |
| Q3 | Nov 3, 2025 | $13.00K | $7.68M | -99.8 % |